Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from National Institutes of Health

Lawsuit blames Fauci and federal agencies for Kansas City musician’s COVID-19 death

KANSAS CITY, Mo. — The widow of a popular Kansas City-area musician has filed a lawsuit accusing Dr. Anthony Fauci and the National Institutes of Health of indirectly causing her husband’s death from COVID-19 by funding coronavirus experimentation at a lab in China.

Tribune News Service · Dec 1, 2022

What is inflammation? Two immunologists explain how the body responds to everything from stings to vaccination and why it sometimes goes wrong

When your body fights off an infection, you develop a fever. If you have arthritis, your joints will hurt. If a bee stings your hand, your hand will swell up and become stiff. These are all manifestations of inflammation occurring in the body.

The Conversation · Nov 7, 2022

No prescription needed: over-the-counter hearing aids on sale in US

Hearing aids now available from stores including Walgreens and Walmart without prescription after new FDA rule takes effect

The Guardian - US · Oct 18, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Texas researchers receive $149 million for large study of Alzheimer’s in racial, ethnic groups

FORT WORTH, Texas — The National Institutes of Health is giving $149 million to researchers at the University of North Texas Health Science Center to pay for researchers to study the biology of Alzheimer’s disease in multiple racial and ethnic groups.

Tribune News Service · Oct 3, 2022

Lab Monkeys Are the Latest Covid Shortage

Beijing’s ban on macaque exports—needed to test vaccines and other lifesaving drugs—could give its pharma industry an edge.

Businessweek · Sep 28, 2022

ARPA-H: High-risk, high-reward health research is the mandate of new, billion-dollar US agency

A new multibillion-dollar federal agency was created with a goal of supporting “the next generation of moonshots for health” in science, logistics, diversity and equality. And the agency now has it’s first leader, as President Joe Biden announced Renee Wegrzyn as director of the Advanced Research Projects Agency for Health,…

The Conversation · Sep 16, 2022

Will omicron-specific booster shots be more effective at combating COVID-19? 5 questions answered

On Sept. 1, 2022, the Centers for Disease Control and Prevention endorsed the use of updated COVID-19 booster shots that are specifically tailored to combat the two most prevalent omicron subvariants, BA.4 and BA.5. The decision comes just a day after the Food and Drug Administration’s emergency use authorization of…

The Conversation · Sep 1, 2022

Read news from The Economist, FT, and more,
with one subscription

Young adults are using marijuana and hallucinogens at the highest rates on record

The National Institutes of Health annually surveys substance abuse among young adults in its Monitoring the Future study.

WEKU · Aug 24, 2022

We need to talk about "mild Covid" — and why it sucks

Early in the pandemic, doctors defined mild, moderate, and severe Covid. Two and a half years later, do they still make sense?

Inverse · Aug 4, 2022

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Avalo Therapeutics (NASDAQ:AVTX) has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER). Avalo shares traded in a range of $3.5 to $3.91 on a day volume of 33.54 thousand shares,…

Benzinga · Aug 2, 2022

Cells become zombies when the ends of their chromosomes are damaged – a tactic both helpful and harmful for health

The Research Brief is a short take about interesting academic work.

The Conversation · Jul 19, 2022

Biomedical grantmakers' diversity push gains new momentum

The Howard Hughes Medical Institute, one of the nation’s wealthiest philanthropies, announced a $1.5 billion effort designed to help scientists of color advance in their careers

The Independent UK · Jul 6, 2022

Efficacy Of Pfizer's Paxlovid COVID Drug Crashes, According To New NIH-Funded Study

A new National Institutes of Health (NIH) funded study sheds new light on the waning effectiveness of Pfizer’s (NYSE: PFE) Paxlovid to prevent patient hospitalizations due to COVID.

Benzinga · Jun 29, 2022

Anthony Fauci tests positive for Covid with mild symptoms

Biden’s chief medical adviser received two booster shots and is working from home, says National Institutes of Health

The Guardian - US · Jun 15, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation · Jun 10, 2022

Why opting out of opioids can be dangerous in the operating room

Currently, patients in seven states can tell their physicians they don’t want to be treated with opioids in any health care setting, even during surgery. While unnecessary opioid exposure is a big reason behind the opioid epidemic in the U.S., we believe that non-opioid directives that allow patients to opt…

The Independent UK · Jun 7, 2022

Former longtime Illinois US Rep. John E. Porter dies at 87

Former Illinois U.S. Rep. John E

St. Louis Post-Dispatch · Jun 3, 2022

Researchers find that 2 drugs reduced COVID-19 deaths

ST. LOUIS — The National Institutes of Health released early results on of a trial involving Washington University, showing that two anti-inflammatory drugs reduced the risk of death in patients with severe COVID-19.

The Conversation · May 31, 2022

The lasting consequences of school shootings on the students who survive them

As the U.S. reels from another school shooting, much of the public discussion has centered on the lives lost: 19 children and two adults. Indeed, the massacre at Robb Elementary School in Uvalde, Texas is the second deadliest such incident on record, after the shooting at Sandy Hook Elementary School…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · May 26, 2022

Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday?

Based on the review of approximately 460 patients, Data Safety and Monitoring Board (DSMB) determined that the evaluation of NRx Pharmaceuticals Inc's (NASDAQ:NRXP) Zyesami (aviptadil) should cease due to futility. Aviptadil was the sole remaining investigational medicine in ACTIV-3b targeted at critical-ill COVID-19 patients. ACTIV-3b study evaluated Zyesami and Gilead Sciences Inc's (NASDAQ:GILD) Veklury (remdesivir)…

The Conversation · May 17, 2022

Zinc is a metal essential to life – scientists have discovered a protein that helps keep cells alive when zinc levels are low

All living things, including people, need zinc in their diets. Getting too little of this essential metal can impair growth and cause immune dysfunction, neurological disorders and cancer. Unfortunately, over 17% of the world’s population is at risk for zinc deficiency. The World Health Organization considers this kind of micronutrient-related…

The Conversation · May 16, 2022

Just how accurate are rapid antigen tests? Two testing experts explain the latest data

As of May 2022, the U.S. is experiencing another uptick in the number of COVID-19 cases. High rates of infection in Europe and Asia, along with the continued emergence of new sub-variants, such as omicron BA.4 and BA.5, raise concerns that another surge could be on the way.

WEKU · May 12, 2022

How COVID vaccines have boosted the development of an HIV vaccine

During the pandemic scientists launched a vaccine in record-breaking time. Their successful use of mRNA technology could lead to progress in the decades-long effort for an HIV inoculation.

Benzinga · May 12, 2022

Senators Cory Booker And Brian Schatz Call On Federal Agencies To Research Psychedelics

Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the FDA whom they called on to study the therapeutic potent

The Conversation · Apr 20, 2022

When it comes to the rarest of diseases, the diagnosis isn't the answer – it's just the starting point

“Mr. and Mrs. Smith, we finally have an answer for you.” The couple, whose real names we are protecting for privacy, looked at me anxiously. I had been evaluating their young daughter, Sally, in my role as a medical geneticist at the Children’s Hospital at Montefiore in the Bronx, a…

Benzinga · Apr 18, 2022

Two long COVID Patients Recover After Pfizer's Therapy; Side Effects, Safety Needs To Be Assessed: Reuters

Reuters reported that two patients found relief from long COVID after taking Pfizer Inc's (NYSE:PFE) antiviral Paxlovid, including a researcher who tested it on herself. Long COVID is estimated to affect up to 30% of people infected with the coronavirus. It can last for months. More than 200 symptoms have been associated with the…

1 … 8 9 10 11

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

598 stories

Centers for Disease Control and Prevention

National Institutes of Health

260 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.